Lee D Cranmer (Lee Cranmer)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 20

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Cancer reports (Hoboken, N.J.)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Lee D Cranmer, Eric Quentin Konnick, Jennifer R Yoshida, Angela L Jacobson, Bilal A Malik, Harveshp Mogal, Lucas B Sullivan, Cynthia L Handfrod, Colin C Pritchard, Marianne E Dubard-Gault
Combined Germline and Mosaic SDHA Mutation Is Associated With a Multicancer Syndrome Including Neuroblastoma, Renal Cancer, and Multifocal GI Tumor. JCO precision oncology 8 (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Lee D Cranmer, Eric Quentin Konnick, Jennifer R Yoshida, Angela L Jacobson, Bilal A Malik, Harveshp Mogal, Lucas B Sullivan, Cynthia L Handfrod, Colin C Pritchard, Marianne E Dubard-Gault
Combined Germline and Mosaic SDHA Mutation Is Associated With a Multicancer Syndrome Including Neuroblastoma, Renal Cancer, and Multifocal GI Tumor. JCO precision oncology 8 (2024)
Andrew J Wagner, Vinod Ravi, Richard F Riedel, Kristen Ganjoo, Brian Andrew Van Tine, Rashmi Chugh, Lee D Cranmer, Erlinda M Gordon, Jason L Hornick, Heng Du, Li Ding, Anita N Schmid, Willis H Navarro, David J Kwiatkowski, Mark A Dickson
Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Cass G G Sunga, Michael S Higgins, Robert W Ricciotti, Yajuan J Liu, Lee D Cranmer
Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::ALK fusion responding to alectinib. Cancer reports (Hoboken, N.J.) 6 (3) (2023)
Cass G G Sunga, Michael S Higgins, Robert W Ricciotti, Yajuan J Liu, Lee D Cranmer
Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::ALK fusion responding to alectinib. Cancer reports (Hoboken, N.J.) (2023)
Cass G G Sunga, Michael S Higgins, Robert W Ricciotti, Yajuan J Liu, Lee D Cranmer
Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::ALK fusion responding to alectinib. Cancer reports (Hoboken, N.J.) 6 (3) (2023)
Cass G G Sunga, Michael S Higgins, Robert W Ricciotti, Yajuan J Liu, Lee D Cranmer
Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::ALK fusion responding to alectinib. Cancer reports (Hoboken, N.J.) 6 (3) (2023)
Lee D Cranmer, Yao Lu, Rachel S Heise, Karla V Ballman, Elizabeth Trice Loggers, Seth M Pollack, Michael J Wagner, Denise K Reinke, Patrick Schöffski, William D Tap
Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft Tissue Sarcomas: Post Hoc Analysis of a Prospective Randomized Trial (SARC021/TH CR-406). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lee D Cranmer, Yao Lu, Rachel S Heise, Karla V Ballman, Elizabeth Trice Loggers, Seth M Pollack, Michael J Wagner, Denise K Reinke, Patrick Schöffski, William D Tap
Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft-Tissue Sarcomas: Post Hoc Analysis of a Prospective Randomized Trial (SARC021/TH CR-406). Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Kelly G Paulson, Vinod Ravi, Brian P Rubin, Min Park, Elizabeth T Loggers, Lee D Cranmer, Michael J Wagner
Incidence, demographics, and survival of malignant hemangioendothelioma in the United States. Cancer medicine (2023)
Cass G G Sunga, Michael S Higgins, Robert W Ricciotti, Yajuan J Liu, Lee D Cranmer
Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::ALK fusion responding to alectinib. Cancer reports (Hoboken, N.J.) 6 (3) (2023)
Shreya Swaminathan, Jacob Ruzevick, Vyshak Venur, Lia M Halasz, Jason Rockhill, Luis Gonzalez-Cuyar, Lee D Cranmer, Manuel Ferreira Jnr
Intracranial Solitary Fibrous Tumor/Hemangiopericytoma Treated with Microsurgical Resection: Retrospective Cohort Analysis of a Single-Center Experience. Therapeutics and clinical risk management 18 (2022)
Lee D Cranmer, Lisa M Hess, Tomoko Sugihara, Howard G Muntz
Cardiac events among patients with sarcoma treated with doxorubicin by method of infusion: A real-world database study. Cancer reports (Hoboken, N.J.) (2022)
Merve Hasanov, Denái R Milton, William H Sharfman, Bret Taback, Lee D Cranmer, Gregory A Daniels, Lawrence Flaherty, Sigrun Hallmeyer, Mohammed M Milhem, Lynn G Feun, Ralph J Hauke, Gary Doolittle, Nancy Gregory, Sapna Pradyuman Patel
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma. Oncoimmunology 10 (1) (2021)
Lee D Cranmer, Bonny Chau, Jose G Mantilla, Elizabeth T Loggers, Seth M Pollack, Teresa S Kim, Edward Y Kim, Gabrielle M Kane, Matthew J Thompson, Jared L Harwood, Michael J Wagner
Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis. Clinical orthopaedics and related research (2021)